MktsMarkets

Adial Pharmaceuticals, Inc
NASDAQ: ADILKey statistics
ADIL News
Stories mentioning ADIL from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 433.00 | 620.00 | 521.00 | 732.00 | 747.00 | 730.00 | 1,032 | 1,013 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 2,001 | 1,885 | 1,764 | 1,883 | 2,267 | 1,941 | 2,211 | 2,287 |
| Operating Income (Loss) | (2,001) | (1,885) | (1,764) | (1,883) | (2,267) | (1,941) | (2,211) | (2,287) |
| Interest Income | 47.00 | 43.00 | 48.00 | 24.00 | 35.00 | 54.00 | 51.00 | 51.00 |
| Interest Expense | ||||||||
| Other Expense | 1.00 | (1.00) | (1.00) | 166.00 | ||||
| Pretax Income | (2,192) | (2,458) | ||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (2,022) | (1,995) | (1,794) | (1,959) | (2,229) | (2,070) | (2,192) | (2,458) |
| Earnings Per Share (Basic) | (1.48) | (3.15) | (0.08) | (0.18) | (8.52) | (64.85) | (0.38) | (0.59) |
| Earnings Per Share (Diluted) | (1.48) | (2.98) | (0.08) | (0.18) | (8.52) | (10.67) | (0.38) | (0.59) |
| Weighted Average Shares Outstanding (Basic) | 1,370 | 22,171 | 262.00 | 5,836 | ||||
| Weighted Average Shares Outstanding (Diluted) | 1,370 | 669.00 | 22,171 | 10,623 | 262.00 | 194.00 | 5,836 | 4,183 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ADIL
Adial Pharmaceuticals, Inc (NASDAQ: ADIL) is a stock listed on the Nasdaq Stock Market under the ticker symbol ADIL. It last traded at $4.09 (Nov 12, 2026, 7:00 PM ET), up 9.4% on the day. That gives Adial Pharmaceuticals a market capitalisation of $12.3M.
Over the past 52 weeks ADIL has traded between $1.31 and $8.75.
For the quarter ended Mar 31, 2026 it reported a net loss of $2.0M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$2.0M |
| Dec 31, 2025 | — | -$2.0M |
| Sep 30, 2025 | — | -$1.8M |
| Jun 30, 2025 | — | -$2.0M |
From Adial Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…